Imbio Receives FDA 510(k) Clearance for New Cardiothoracic Imaging Algorithm

MINNEAPOLIS, March 16, 2021 -- (Healthcare Sales & Marketing Network) -- Imbio, a leading provider of artificial intelligence (AI) solutions for medical imaging analysis, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its RV/LV ... Devices, Cardiology, Radiology, FDA Imbio, RV/LV Analysis, pulmonary embolism
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news